Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Allogeneic Stem Cell Transplant Complications”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Large-scale testing (Phase 3)UnknownNCT03371667
What this trial is testing

To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids

Who this might be right for
Allogeneic DiseaseGVH - Graft Versus Host ReactionGVHD, Acute+1 more
Assistance Publique - Hôpitaux de Paris 102
Not applicableStudy completedNCT01374399
What this trial is testing

Physical Exercise Therapy vs Relaxation in Allogeneic Stem Cell Transplantation (PETRA)

Who this might be right for
Allogeneic Stem Cell Transplantation
German Cancer Research Center 267
Not applicableLooking for participantsNCT06198517
What this trial is testing

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang 266
Testing effectiveness (Phase 2)UnknownNCT04809181
What this trial is testing

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
First Affiliated Hospital of Zhejiang University 95
Not applicableUnknownNCT04502628
What this trial is testing

Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

Who this might be right for
Stem Cell Transplant Complications
Shandong Provincial Hospital 150
Large-scale testing (Phase 3)Looking for participantsNCT03394365
What this trial is testing

Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Who this might be right for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament
Not applicableStudy completedNCT02032381
What this trial is testing

Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.

Who this might be right for
Bone Marrow Transplant InfectionBronchiolitis ObliteransChronic Respiratory Insufficiency+2 more
Assistance Publique - Hôpitaux de Paris 300
Large-scale testing (Phase 3)Looking for participantsNCT04832607
What this trial is testing

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Who this might be right for
AdV InfectionEBV InfectionCMV Infection+1 more
Tobias Feuchtinger 149
Testing effectiveness (Phase 2)Study completedNCT01509560
What this trial is testing

PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood

Who this might be right for
Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Not applicableUnknownNCT06022445
What this trial is testing

Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCT

Who this might be right for
Stem Cell Transplant Complications
Peking University People's Hospital 200
Not applicableNot Yet RecruitingNCT05087784
What this trial is testing

AlloLife - Life After Transplantation

Who this might be right for
SurvivorshipStem Cell Transplant Complications
University Hospital, Essen 192
Not applicableStudy completedNCT05886335
What this trial is testing

Influence of Timing PTCy in AlloSCT

Who this might be right for
Cyclophosphamide ToxicityAllogenic Haematopoetic Transplantation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 180
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableNot Yet RecruitingNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Not applicableAvailableNCT07104591
What this trial is testing

TETRAVI Expanded Access Program

Who this might be right for
Epstein-Barr Virus InfectionCytomegalovirus InfectionsAdenovirus Infection+4 more
Baylor College of Medicine
Not applicableUnknownNCT04051372
What this trial is testing

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL

Who this might be right for
Bronchoalveolar Lavage FluidLung Infection
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 250
Not applicableEnded earlyNCT02360111
What this trial is testing

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Load More Results
115
190